Athanase Innovation AB Cash Flow Reinvestment Rate
Athanase Innovation AB cash flow reinvestment rate. Athanase Innovation AB (ATIN) has a Cash Flow Reinvestment Rate of 0.99x as of June 2024, reinvesting Skr6.49 Million (capex Skr6.49 Million ) from operating cash flow of Skr6.54 Million. Explore Athanase Innovation AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Athanase Innovation AB (2018–2021)
Cash flow reinvestment rate of Athanase Innovation AB from 2018 to 2021. Historical reinvestment intensity for Athanase Innovation AB across 4 annual periods. Explore Athanase Innovation AB capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Athanase Innovation AB Cash Flow Reinvestment Rate by Year (2018–2021)
Athanase Innovation AB cash flow reinvestment rate by year from 2018 to 2021. Year-by-year capital reinvestment analysis for Athanase Innovation AB. For the full cash flow conversion analysis, see ATIN cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 9.19x | Skr212.40 Million | Skr23.10 Million | Skr65.00K | — |
| 2020 | 0.00x | Skr0.00 | Skr22.34 Million | Skr0.00 | — |
| 2019 | 0.00x | Skr0.00 | Skr28.38 Million | Skr0.00 | — |
| 2018 | 0.00x | Skr0.00 | Skr15.05 Million | Skr0.00 | — |